Published online before print December 13, 2001, doi: 10.1161/hh0202.103615
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2002 American Heart Association, Inc.
Molecular Medicine |
Essential Role of the NADPH Oxidase Subunit p47phox in Endothelial Cell Superoxide Production in Response to Phorbol Ester and Tumor Necrosis Factor-
From the Department of Cardiology (J.-M.L., A.M.M., S.Y., A.M.S.), Guy’s King’s & St Thomas’ School of Medicine (Denmark Hill Campus), King’s College London, London, UK; the Department of Medicine (F.W.), University College London, UK; and the Molecular Immunology Unit (G.Y.B., A.J.T.), Institute of Child Health, London, UK.
Correspondence to Ajay M. Shah, MD, FRCP, Dept of Cardiology, GKT School of Medicine (Denmark Hill Campus), Bessemer Road, London SE5 9PJ, UK. E-mail ajay.shah{at}kcl.ac.uk
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
A phagocyte-type NADPH oxidase complex is a major source of endothelial reactive oxygen species (ROS) production, but its biochemical function and regulation remain unclear. In neutrophils, the p47phox subunit is centrally involved in oxidase activation in response to agonists such as phorbol-12-myristate-13-acetate (PMA). We investigated the role of p47phox in endothelial cell ROS production in response to PMA or tumor necrosis factor-
(TNF) stimulation. To specifically address the role of p47phox, we studied coronary microvascular endothelial cells (CMECs) isolated from p47phox-/- mice and wild-type controls. p47phox was absent in hearts of knockout mice whereas the essential oxidase subunit, p22phox, was expressed in both groups. In the absence of agonist stimulation, the lack of p47phox did not result in a reduction in NADPH-dependent ROS production in p47phox-/- CMECs compared with wild-type CMECs. Prestimulation with PMA (100 ng/mL) or TNF (100 U/mL) for 10 minutes significantly increased NADPH-dependent O2- production in wild-type CMECs, assessed either by lucigenin (5 µmol/L) chemiluminescence or dichlorohydrofluorescein (DCF) fluorescence. This response was completely lost in p47phox-/- cells. Transfection of the full-length p47phox cDNA into p47phox-/- CMECs caused expression of p47phox protein and restoration of the O2- response to PMA and TNF. In wild-type CMECs, transfection of antisense p47phox cDNA substantially reduced p47phox expression and caused loss of the O2- response to PMA and TNF. These data show that endothelial cell p47phox is critical in the upregulation of NADPH oxidase activity by PMA and TNF.
Key Words: knockout mice • p47phox • endothelial cells • NADPH oxidase • reactive oxygen species
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The neutrophil NADPH oxidase complex comprises a membrane-associated low-potential cytochrome b558 composed of one p22phox and one gp91phox subunit and several cytosolic regulatory subunits (p47phox, p40phox, p67phox, and Rac1 or Rac2).1 The enzyme is normally dormant but is rapidly activated on appropriate stimulation, and generates millimolar amounts of superoxide (O2-) in a process that requires NADPH as cofactor. Neutrophil NADPH oxidase activation is an integral part of nonspecific host defense and involves the translocation and association of cytosolic subunits with the membrane bound cytochrome b558. Recently, phagocyte-type NADPH oxidases have been identified in other cell types, including adventitial fibroblasts,2 vascular smooth muscle (VSM),3 endothelial cells (ECs),4–6 and renal mesangial cells7; the enzyme is thought to serve a signaling function in these cells. An increase in NADPH oxidase activity and/or expression in VSM and adventitial fibroblasts is implicated in the pathophysiology of hypertension, atherosclerosis, and diabetes.2,3,8–10
Several groups, including our own, have shown that all subunits of a phagocyte-type NADPH oxidase are expressed in ECs.5,6,11,12 The oxidase appears to be functionally active as manifest by significant NADPH-dependent O2- production and is a major source of endothelial reactive oxygen species (ROS) such as H2O2.6,11 EC ROS production is known to be involved in the pathophysiology of disorders such as hypercholesterolemia, atherosclerosis, and ischemia-reperfusion.13 ROS can rapidly inactivate nitric oxide (NO), lead to the formation of peroxynitrite, and modulate redox-sensitive intracellular signaling pathways. Endothelial ROS production is increased by several stimuli, eg, phorbol esters (which activate protein kinase C, PKC), tumor necrosis factor- (TNF-), pulsatile stretch, and hypoxia-reoxygenation.13–16 However, the precise role of NADPH oxidase in endothelial ROS production in response to these stimuli remains unclear. Evidence has been provided for an involvement of Rac1,16,17 but there is little information regarding the role of other oxidase subunits.
p47phox plays a pivotal role in neutrophil NADPH oxidase activation by providing physical binding domains to cytochrome b558 and p67phox.18,19 Agonists such as PMA cause p47phox phosphorylation and initiate activation of the neutrophil oxidase.20–22 Genetic mutations of p47phox result in loss of O2- production during neutrophil activation and cause autosomal recessive forms of chronic granulomatous disease (CGD), which is characterized by recurrent infection.1 Gene-modified mice lacking p47phox have been generated by 2 laboratories; these animals develop a clinical syndrome similar to CGD.23,24
The aim of the present study was to investigate the role of p47phox in O2- production by ECs in response to agonists known to increase ROS, namely PMA and TNF. Studies were undertaken in coronary microvascular ECs (CMECs) isolated from p47phox-/- and matched p47phox+/+ wild-type mice.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Reagents
Culture medium, fetal calf serum (FCS), glutamine, antibiotics, and Lipofectamine Plus reagent were purchased from Gibco BRL (UK); collagenase type II from Lorne Laboratories (UK); EC growth supplement, gelatin, trypsin, DNAse, lucigenin, NADPH, NADH, diphenyleneiodonium (DPI), tiron, and superoxide dismutase (SOD) from Sigma (UK); acetylated low-density lipoprotein labeled with 1,1-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (Di1-Ac-LDL) from Biogenesis Ltd (UK); and 5-(and 6)-chloromethyl-2',7'-dichlorodrofluorescein diacetate (DCF) from Molecular Probes (UK).
Animals
129sv mice deficient in p47phox were generated by targeted disruption of the p47phox gene and were kindly provided by Dr Jurgen Roes (University College London, UK).24 Neutrophils of p47phox-/- mice are unable to mobilize the oxidative response (ie, have no ROS production) in response to PMA or opsonized C. albicans.24 Animals were used at 8 to 10 weeks of age. All experiments were performed in accordance with the Guidance on the Operation of Animals (Scientific Procedures) Act, 1986 (Her Majesty’s Stationery Office, UK).
CMEC Isolation
Six mouse hearts were used for each CMEC preparation. After ethanol exposure to devitalize epicardial mesothelial cells, ventricular tissue was minced and predigested in collagenase (1 mg/mL in HBSS) to separate cardiomyocytes and other cells. The residual tissue pellet was used for CMEC isolation. The pellet was digested 3 times (10 minutes each) with 8 mL isolation buffer containing trypsin 0.05%, DNAse 1 µg/mL, EDTA 0.1 mmol/L, and glucose 2 mg/mL in HBSS incubated at 37°C, with shearing every 3 minutes. Tissue debris was spun down at 25g, and CMECs in the supernatant were spun down at 120g (4°C). CMECs were seeded onto gelatin-coated flasks in growth medium containing DMEM supplemented with 20% FBS, EC growth supplement (50 µg/mL), 2-mercaptoethanol (5 µmol/L), L-glutamine (2 mmol/L), penicillin (50 U/mL), and streptomycin (50 µg/mL) and cultured at 37°C with 5% CO2. After 2 hours, floating cells were removed by replacing medium. After 24 hours, cells were washed and the medium was renewed. CMECs were used at passage 2. EC identity and purity was confirmed by Di1-Ac-LDL uptake, and expression of CD31, VE-cadherin, and eNOS by >98% of cells. CMECs were negative for -smooth muscle actin and cytokeratin.
Northern Analyses
Northern blotting was performed using [-32P]dCTP labeled full-length p47phox and p22phox cDNA probes,25 and 10 µg/lane total RNA extracted from ventricular tissues. Membranes were rehybridized with a GAPDH cDNA as an internal control for RNA loading and transfer efficiency.
Immunoblotting
Protein samples were prepared from CMECs lysed directly in SDS sample buffer containing Tris-HCl (50 mmol/L) and SDS 1% (pH 7). Cells were scratched into centrifuge tubes, extracted on ice for 15 minutes, and centrifuged at 200g for 5 minutes at 4°C. Soluble protein concentration was determined using a Bio-Rad kit (Bio-Rad Laboratories, UK). Immunoblotting (25 µg protein per sample) was performed as described previously.26 p47phox was detected with a specific polyclonal antibody raised against human neutrophil p47phox.27 The protein extract from human phagocytic U937 cells after stimulation with PMA served as a positive control. Anti–-tubulin monoclonal antibody was purchased from Transduction Laboratories.
ROS Production
Three different methods were used for detection of ROS. Lucigenin (5 µmol/L)-enhanced chemiluminescence was used as described previously.17,28 Briefly, CMECs were detached with trypsin/EDTA and resuspended in modified HEPES buffer containing (mmol/L) NaCl 140, KCl 5, MgCl2 0.8, CaCl2 1.8, Na2HPO4 1, HEPES 25, and 1% glucose (pH=7.2). Cells were distributed at 5x104/well on to a 96-well microplate luminometer (Lucy 1, Rosys Anthos). Immediately before recording, NADPH (100 µmol/L) and dark-adapted lucigenin (5 µmol/L) were added to cell suspensions. Light emission was recorded every minute for 20 minutes and was expressed as mean arbitrary light units/minute. Experiments were performed in triplicate; all results are from at least 3 independent experiments. In experiments with O2- scavengers, ie, SOD (200 U/mL) or tiron (5 mmol/L), or with inhibitors, ie, DPI (10 to 250 µmol/L), N-
-nitro-L-arginine methyl ester (L-NAME, 100 µmol/L), rotenone (50 µmol/L), or oxypurinol (100 µmol/L), these were preincubated with CMECs for 10 minutes. PMA or TNF were added 10 minutes before NADPH addition and recording of chemiluminescence.
We also performed additional experiments using CMEC homogenates. Lucigenin-enhanced chemiluminescence was measured in exactly the same way as described above apart from the use of cell homogenate (100 µg/well) rather than intact cells. In experiments with PMA, this was preincubated with CMECs at 37°C before preparation of cell homogenates.
ROS generation by intact CMECs was also measured by DCF fluorescence.29 Briefly, adherent cells cultured on chamber slides were washed in Hanks’ buffer, then exposed either to PMA (100 ng/mL) or buffer alone for 10 minutes. Experiments were undertaken in parallel in the presence or absence of NADPH (100 µmol/L). Cells were then incubated with 10 µmol/L DCF in Hanks’ buffer for 30 minutes at room temperature. DCF fluorescence at an excitatory wavelength of 495 nm was acquired on a Zeiss microscope coupled to a digital imaging system (Improvision). Fluorescence intensity was quantified from at least 3 random fields (1024x1022 pixels; 269.7x269.2 µm) per slide (100 cells assessed per slide) and 3 slides per experimental condition.
In some experiments, NADPH-dependent O2- production by CMEC homogenates was examined using SOD-inhibitable cytochrome c reduction assay. CMEC homogenate (final concentration 1 mg/mL) diluted in DMEM without phenol red was distributed in 96-well flat-bottom culture plates (final volume 200 µL/well). Cytochrome c (500 µmol/L) and NADPH (100 µmol/L) were added in the presence or absence of SOD (200 U/mL) and incubated at room temperature for 30 minutes. Cytochrome c reduction was measured by reading absorbance at 550 nm on a microplate reader. O2- production in nmol/mg protein was calculated from the difference between absorbance with or without SOD and the extinction coefficient for change of ferricytochrome c to ferrocytochrome c, ie, 21.0 mmol · L-1 · cm-1.
CMEC Transfection
The full-length human neutrophil p47phox cDNA25 was subcloned in sense and antisense orientations into the expression vector pcDNA3 (Invitrogen). Inserted cDNA orientation was confirmed by restriction digest analysis. Transfection was undertaken with Lipofectamine Plus reagent (Gibco) in serum-free DMEM according to the manufacturer’s instructions. In preliminary studies with a plasmid vector containing the E.coli ß-galactosidase gene (Clonech, Palo Alto, Calif) and X-gal visualization, a transfection efficiency of 
60% could be achieved at a ratio of plasmid/Plus reagent/lipofectamine of 3/5/5 (wt/vol/week). On the day before transfection, passage 2 CMECs were counted and seeded (2x106 cells) into T-75 flasks to reach 90% confluence. The transfection medium was prepared by mixing 3 µg/mL of cDNA construct with 5 µL/mL Plus reagent and incubating at room temperature for 15 minutes. Diluted lipofectamine (final concentration 5 µg/mL) was added and the mixture incubated for 15 minutes at room temperature. Cells were washed twice with serum-free DMEM before adding transfection medium (3 mL per flask) and were incubated for 4 hours at 37°C in 95% air/5% CO2. At the end of incubation, 3 mL DMEM supplemented with 20% FCS was added and cells incubated overnight. The next day, the medium was replaced with appropriate culture medium. Cells were harvested after 72 hours of transfection.
Statistics
ROS data are presented as mean±SD of at least 3 different experiments for each condition. Comparisons were made by unpaired t test, with Bonferonni correction for multiple testing. A value of P<0.05 was considered statistically significant.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Expression of p47phox mRNA and Protein
Northern blot analysis demonstrated the presence of p47phox mRNA in wild-type hearts but not p47phox-/- hearts (Figure 1). In contrast, mRNA expression of the essential oxidase subunit, p22phox, was similar in both groups. p47phox protein was present in wild-type CMECs but not p47phox-/- CMECs (Figure 4A), but was undetectable in whole heart homogenates (not shown).
|
|
CMEC NADPH Oxidase Activity in the Absence of Agonist Stimulation
Using lucigenin-enhanced chemiluminescence, a very low level of O2- was detected in intact CMECs in the absence of added NADPH (Figure 2A). Addition of NADPH (100 µmol/L) resulted in substantially greater O2- production by both p47phox-/- and p47phox+/+ cells, whereas NADH or xanthine addition had no effect. Unexpectedly, this O2- production was significantly (P<0.01) higher in p47phox-/- cells. The higher level in p47phox-/- CMECs was not due to differences in endogenous SOD activity because the higher O2- production persisted after preincubation with an SOD inhibitor, DDC (data not shown). NADPH-dependent CMEC O2- production was virtually abolished by a flavoprotein inhibitor, DPI, or a cell-permeable O2- scavenger, tiron (Figure 2B). Exogenous SOD inhibited 60% of CMEC O2- production. Neither the xanthine oxidase inhibitor, oxypurinol, nor the NOS inhibitor, L-NAME, had any effect on NADPH-dependent O2- production. Rotenone reduced p47phox-/- CMEC O2- production by 15%, which could reflect a small amount of mitochondrial production, but had no effect on p47phox+/+ CMECs.
|
Similar results were obtained in experiments performed with CMEC homogenate (Figure 2C). NADPH-dependent O2- production by p47phox-/- CMEC homogenate was significantly higher than by p47phox+/+ homogenate, with minimal NADH-dependent O2- production in either group.
As an alternative approach, specific NADPH oxidase activity was assessed in homogenates of adherent CMECs by SOD-inhibitable cytochrome c reduction assay. Using this method, NADPH-dependent O2- production by p47phox-/- CMEC homogenate was still significantly increased compared with p47phox+/+ cells (Figure 2D).
PMA- and TNF-Induced O2- Production
We next examined the effect of acute CMEC treatment with PMA or TNF, both of which increase EC ROS production.14,30,31 In the absence of added NADPH, there was no clear difference in O2- production with or without PMA or TNF in either group of cells. In the presence of exogenous NADPH, O2- production was significantly increased in wild-type CMECs preexposed to PMA or TNF (Figures 3A and 3B, top panels). O2- production was fully inhibited by DPI. However, in p47phox-/- CMECs, neither PMA nor TNF induced any increase in NADPH-dependent O2- production (Figure 3A and 3B, bottom panels).
|
Similar results were obtained with the use of homogenate from wild-type and p47phox-/- CMECs that had been prestimulated with PMA (Table). In the wild-type group, PMA prestimulation resulted in a significant increase in NADPH oxidase activity. This was completely inhibited in the p47phox-/- group. Note that the level of superoxide production in PMA prestimulated wild-type CMEC homogenate was substantially higher than in the p47phox-/- group under basal conditions.
|
Effect of p47phox Sense or Antisense cDNA Transfection on Protein Expression and on Oxidase Response to PMA and TNF
CMECs isolated from p47phox-/- and p47phox+/+ mice were studied in parallel. p47phox-/- CMECs were transfected with sense p47phox cDNA or empty vector control; p47phox+/+ CMECs were transfected with antisense or sense p47phox cDNA or empty vector control. Three days after transfection, CMECs were trypsinized and split into 2 portions; one was used to examine protein expression and the other to assay O2- generation.
Transfection of wild-type CMECs with antisense p47phox cDNA resulted in a substantial reduction in p47phox protein expression, whereas transfection with sense p47phox cDNA had no effect on expression (Figure 4A). p47phox protein was undetectable in p47phox-/- CMECs (Figure 4A). Transfection of p47phox-/- cells with sense p47phox cDNA resulted in significant expression of p47phox. Protein from U937 cells and human umbilical vein ECs (HUVECs) served as a positive control for p47phox expression. Equal loading of samples in these experiments was confirmed by Coomassie Blue staining of membranes (not shown) as well as by probing for -tubulin (Figure 4A).
Figure 4B shows representative examples of the response of transfected CMECs to PMA or TNF stimulation. Measurable changes in CMEC O2- production were only detected in the presence of exogenous NADPH. In control wild-type CMECs, preexposure to PMA or TNF resulted in an increased O2- production (Figure 4B, top left panel). However, in antisense p47phox cDNA-transfected cells, the PMA- or TNF-induced increase in O2- production was abolished (Figure 4B, top right panel). Indeed, there was a significant decrease in O2- production after PMA or TNF. This profile of O2- production mirrored that of the control p47phox-/- CMECs (Figure 4B, bottom left panel). In p47phox-/- CMECs transfected with sense p47phox cDNA, the oxidase response to PMA and TNF stimulation was fully restored (Figure 4B, bottom right panel), and this mimicked the profile of control wild-type CMECs (Figure 4B, top left panel).
Mean data from 3 independent isolates of p47phox+/+ and p47phox-/- CMECs are shown in Figure 5.
|
CMEC ROS Production Assessed by DCF Fluorescence
To confirm the results obtained in lucigenin assays, additional studies were undertaken using DCF fluorescence in adherent CMECs on chamber slides to assess ROS production. Under baseline conditions in the absence of PMA, there was a small amount of DCF fluorescence detectable above background in wild-type CMECs (Figure 6A; Figure 7A, left). This was significantly increased in PMA-pretreated cells (Figure 6B; Figure 7A, left). In antisense p47phox cDNA-transfected wild-type cells, the increase in ROS production in response to PMA was completely abolished (Figure 6D versus 6C; Figure 7A, right). Although the baseline level of DCF fluorescence tended to be higher in antisense p47phox cDNA-transfected cells compared with wild-type CMECs, this did not achieve statistical significance.
|
|
Broadly similar results were obtained in experiments performed in the presence of exogenous NADPH, except that intracellular fluorescence intensity was markedly increased in all groups. Figure 6F versus 6E and Figure 7B (left) show a significant increase in DCF fluorescence following PMA stimulation in wild-type cells. Figure 6H versus 6G and Figure 7B (right) illustrates that in antisense cDNA-transfected cells, the PMA-induced increase in ROS was completely abolished. Indeed, PMA pretreatment of antisense cDNA-tranfected cells resulted in a significant decrease in ROS production compared with antisense cDNA tranfection alone.
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
This study investigated the role of the NADPH oxidase subunit p47phox in ROS production by mouse CMECs. The absence of p47phox in CMECs of p47phox-/- mice, which were generated to disrupt neutrophil NADPH oxidase, indicates that the p47phox protein expressed in neutrophils and ECs is a product of the same gene. The major finding of this study was that acute PMA- or TNF
-induced increases in CMEC NADPH oxidase activity and ROS production were absolutely dependent on the presence of p47phox. This finding is analogous to the failure to mobilize the respiratory burst in p47phox-/- neutrophils in response to PMA or other agonists.24 However, CMEC NADPH oxidase activity and ROS production in the absence of these agonists did not appear to require p47phox.
Role of p47phox in Agonist-Stimulated CMEC NADPH Oxidase Activity
Although EC ROS production is known to be increased by PMA and TNF-,14,30,31 the involvement of NADPH oxidase in this response has not been established. PMA has been widely used as a PKC agonist and causes p47phox phosphorylation and activation of phagocyte NADPH oxidase.20–22 We found that short-term stimulation with PMA significantly increased NADPH-dependent ROS production by CMECs, assessed either by lucigenin chemiluminescence in cell suspensions or cell homogenates or by DCF fluorescence in adherent cells. This response was absolutely dependent on the presence of p47phox, because it was lost in p47phox-/- CMECs. Furthermore, in vitro cDNA transfection of p47phox into p47phox-/- CMECs successfully rescued the O2- response to PMA whereas in vitro depletion of p47phox from wild-type CMECs by antisense cDNA transfection resulted in loss of the PMA response. These results convincingly demonstrate the essential role of p47phox in CMEC ROS production in response to PMA. Interestingly, in CMECs lacking p47phox (either p47phox-/- cells or antisense cDNA-transfected cells) there was a clear tendency for a reduction in NADPH-dependent O2- production in PMA-stimulated cells, which was significant in some sets of experiments (eg, Figure 5) although not all (eg, Figure 3). The explanation for this finding remains to be elucidated, but in neutrophils lacking p47phox, it is reported that there is a dysregulation of the PKC-ß isoform and that stimulation with PMA causes hyperphosphorylation of other proteins.22
We also examined the role of p47phox in CMEC O2- production in response to a different agonist, TNF. TNF is reported to increase ROS production in several cell types,3,13 including ECs.14,30 Although TNF activates EC PKC,31 it has been reported that TNF-stimulated O2- production by HUVECs is not blocked by PKC inhibitors.30,32 Surprisingly, we found that CMECs that were acutely stimulated with TNF responded in a similar manner as to PMA stimulation in terms of their NADPH-dependent O2- generation and the requirement for p47phox. Wild-type CMECs stimulated with TNF showed an increase in NADPH-dependent O2- production whereas p47phox-/- CMECs stimulated with TNF showed either no response or a reduction in O2- production. In vitro transfection experiments with rescue of p47phox-/- cells or antisense depletion of wild-type cells also generated results consistent with an essential role for p47phox in TNF-mediated stimulation of CMEC NADPH oxidase activity. However, the precise signal transduction pathways through which acute TNF stimulation increases EC NADPH oxidase activity remain to be defined.
Role of p47phox in CMEC NADPH Oxidase Activity in the Absence of Agonists
During neutrophil activation, the absence of p47phox is associated with markedly impaired ROS production.1,23,24 However, the continuous low-level NADPH oxidase activity that is observed in the absence of agonist stimulation in ECs and other nonphagocytic cell types3 has no obvious functional correlate in neutrophils, and its underlying basis is not well understood. It was notable that the absence of p47phox in CMECs did not result in a loss or reduction of NADPH-dependent ROS production, either in intact cells or in cell homogenates (Figures 2, 5, 6, and 7). On the contrary, NADPH-dependent ROS production was significantly higher in CMECs lacking p47phox, as assessed by 3 different methods: lucigenin chemiluminescence (both in intact cells and in cell homogenates), DCF fluorescence, and SOD-inhibitable cytochrome c reduction. Furthermore, the results of manipulation of p47phox expression levels in the in vitro transfection studies were consistent with the possibility that this difference was indeed related to the deficiency of p47phox. Thus, in vitro depletion of p47phox resulted in an increase in NADPH-dependent ROS production (Figures 5 and 7B), whereas reintroduction of p47phox into p47phox-/- CMECs had opposing effects.
A potential limitation of the lucigenin chemiluminescence and some of the DCF fluorescence experiments is that the assays involved the addition of exogenous NADPH to increase ROS production by intact CMECs. The approach of adding exogenous NADPH to assess NADPH oxidase activity has been used previously by several groups, both in intact cells and intact tissues,9,11,17,33–35 and has been shown (1) to be specifically inhibited by DPI but not inhibitors of other flavoproteins (as in the present study),9,11,17,33–35 and (2) to correlate well with specific NADPH oxidase activity measured in parallel in tissue homogenates.9 However, this approach is subject to criticism on the basis that the precise mechanism through which exogenous NADPH acts in this setting is uncertain. On the other hand, in the present study we also found that specific NADPH oxidase activity measured in cell homogenates either by lucigenin chemiluminescence or by the SOD-inhibitable cytochrome c reduction assay was higher in p47phox-/- compared with wild-type CMECs (in the absence of agonist stimulation), indicating that the difference between wild-type and p47phox-/- cells was not simply a reflection of the method used. Nevertheless, the precise relevance of this finding in terms of the biochemical function of the NADPH oxidase complex in ECs requires further study. It is of interest that recent studies of the neutrophil system have shown that in a cell-free system, NADPH oxidase could be activated in the total absence of p47phox if high concentrations of p67phox and Rac1 were present.36,37
Conclusions
This is the first report to specifically explore the role of the NADPH oxidase subunit p47phox in ROS production by ECs. The combination of experiments in CMECs isolated from p47phox-/- mice and the in vitro transfection studies specifically targeting p47phox expression clearly demonstrate the obligatory role of this subunit in EC NADPH-dependent ROS production in response to PMA and TNF. Consistent with an important role for p47phox in agonist-stimulated ROS production by ECs, a recent study reported that hypercholesterolemia-induced leukocyte-ECs adhesion was significantly reduced in p47phox-/- mice, an effect that was attributed to reduced O2- production and involved both the endothelium and white cells.38 The present results add to the increasing body of evidence that suggests an important pathophysiological role for a phagocyte-type NADPH oxidase in EC ROS production.
|
Acknowledgments |
|---|
This work was supported by British Heart Foundation (BHF) Program Grant RG/98008. A.M.S. holds the BHF Chair of Cardiology in King’s College London.
Received February 8, 2001; revision received July 17, 2001; accepted December 3, 2001.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1. Babior BM. NADPH oxidase: an update. Blood. 1999; 93: 1464–1476.
2.
Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A. 1997; 94: 14483–14488.
3.
Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000; 86: 494–501.
4. Mohazzab-H KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994; 266: H2568–H2572.[Medline] [Order article via Infotrieve]
5. Jones SA, O’Donnell VB, Wood JD, Broughton JP, Hughes EJ, Jones OTG. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol. 1996; 271: H1626–H1634.[Medline] [Order article via Infotrieve]
6. Bayraktutan U, Draper N, Lang D, Shah AM. Expression of a functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells. Cardiovasc Res. 1997; 38: 256–262.[CrossRef]
7. Jones SA, Hancock JT, Jones OTG, Neubauer A, Topley N. The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. J Am Soc Nephrol. 1995; 5: 1483–1491.[Abstract]
8.
Warnholtz A, Nickenig G, Schulz E, Macharzina R, Bräsen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Böhm M, Meinertz T, Münzel T. Increased NADH-oxidase–mediated superoxide production in the early stages of atherosclerosis. Circulation. 1999; 99: 2027–2033.
9. Guzik TJ, West NEJ, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Vascular superoxide production by NAD(P)H oxidase. Circ Res. 2000; 86: e85–e90.[Medline] [Order article via Infotrieve]
10.
Münzel T, Harrison DG. Increased superoxide in heart failure. Circulation. 1999; 100: 216–218.
11.
Görlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res. 2000; 87: 26–32.
12.
Bayraktutan U, Blayney L, Shah AM. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscl Thromb Vasc Biol. 2000; 20: 1903–1911.
13.
Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999; 85: 753–766.
14. Matsubara T, Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol. 1986; 137: 3295–3298.[Abstract]
15.
De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res. 1998; 82: 1094–1101.
16. Kim KS, Takeda K, Sethi R, Pracyk JB, Tanaka K, Zhou YF, Yu ZX, Ferrans VJ, Bruder JT, Kovesdi I, Irani K, Goldschmidt-Clermont P, Finkel T. Protection from reoxygenation injury by inhibition of rac1. J Clin Invest. 1998; 101: 1821–1826.[Medline] [Order article via Infotrieve]
17.
Hu Q, Zheng G, Zweier JL, Deshpande S, Irani K, Ziegelstein RC. NADPH oxidase activation increases the sensitivity of intracellular Ca2+ store to inositol 1,4,5-trisphophate in human endothelial cells. J Biol Chem. 2000; 275: 15749–15757.
18. Morozov I, Lotan O, Joseph G, Gorzalczany Y, Pick E. Mapping of functional domains in p47phox involved in the activation of NADPH oxidase by "peptide walking". J Biol Chem. 1997; 273: 15435–15444.[CrossRef]
19.
McPhail LC. SH3-dependent assembly of the phagocyte NADPH oxidase. J Exp Med. 1994; 180: 2011–2015.
20.
Rotrosen D, Leto TL. Phosphorylation of neutrophil 47-kDa cytosolic oxidase factor. J Biol Chem. 1990; 265: 19910–19915.
21. Karisson A, Nixon JB, McPhail LC. Phorbol myristate acetate induces neutrophil NADPH-oxidase activity by two separate signal transduction pathways: dependent or independent of phosphatidylinositol 3-kinase. J Leukoc Biol. 2000; 67: 396–402.[Abstract]
22. Reeves EP, Dekker LV, Forbes LV, Wientjes FB, Grogan A, Pappin DJC, Segal AW. Direct interaction between p47phox and protein kinase C: evidence for targeting of protein kinase C by p47phox in neutrophils. Biochem J. 1999; 344: 859–866.[CrossRef][Medline] [Order article via Infotrieve]
23. Chang YC, Segal BH, Holland SM, Miller GF, Kwon-Chung KJ. Virulence of catalase-deficient aspergillus nidulans in p47phox-/- mice. J Clin Invest. 1998; 101: 1843–1850.[Medline] [Order article via Infotrieve]
24. Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 2000; 12: 201–210.[CrossRef][Medline] [Order article via Infotrieve]
25. Abo A, Boyhan A, West I, Thrasher AJ, Segal AW. Reconstitution of neutrophil NADPH oxidase activity in the cell-free system by four components: p67-phox, p47-phox, p21rac1, and cytochrome b-245. J Biol Chem. 1993; 267: 16767–16771.
26. Li J-M, Poolman RA, Brooks G. Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats. Am J Physiol. 1998; 275: H814–H822.[Medline] [Order article via Infotrieve]
27. Wientjes F, Segal A, Hartwig J. Immunoelectron microscopy shows a clustered distribution of NADPH oxidase components in the human neutrophil plasma membrane. J Leukocyte Biol. 1997; 61: 303–312.[Abstract]
28.
Li Y, Zhu H, Kuppusamy P, Roubaud V, Zweier J, Trush MA. Validation of lucigenin (Bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem. 1998; 273: 2015–2023.
29.
Li AE, Ito H, Rovira II, Kim K-S, Takeda K, Yu Z-Y, Ferrans VJ, Finkel T. A role for reactive oxygen species in endothelial cell anoikis. Circ Res. 1999; 85: 403–310.
30.
Murphy HS, Shayman JA, Till GO, Mahrougui M, Owens CB, Ryan US, Ward PA. Superoxide responses of endothelial cells to C5a and TNF-: divergent signal transduction pathways. Am J Physiol. 1992; 263: L51–L59.[Medline]
[Order article via Infotrieve]
31.
Terry CM, Clikeman JA, Hoidal JR, Callahan KS. TNF-, and IL-1 induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells. Am J Physiol. 1999; 276: H1493–H1501.[Medline]
[Order article via Infotrieve]
32.
Weber C, Erl W, Pietsch A, Ströbel M, Ziegler-Heitbrock HWL, Weber PC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-
B mobolization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb Vasc Biol. 1994; 14: 1665–1673.
33.
Brandes RP, Barton M, Philippens KMH, Schweitzer G, Mugge A. Endothelial-derived superoxide anions in pig coronary arteries: evidence from lucigenin chemiluminescence and histochemical techniques. J Physiol. 1997; 500: 331–342.
34. Pagano PJ, Ito Y, Tornheim K, Gallop PM, Tauber AI, Cohen RA. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol. 1995; 268: H2274–H2280.[Medline] [Order article via Infotrieve]
35.
Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, Runge MS. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. J Biol Chem. 1999; 274: 19814–19822.
36. Freeman JL, Lambeth JD. NADPH oxidase activity is independent of p47phox in vitro. J Biol Chem. 1996; 271: 22587–22582.
37.
Koshkin V, Lotan O, Pick E. The cytosolic component p47phox is not a sine qua non participant in the activation of NADPH oxidase but is required for optimal superoxide production. J Biol Chem. 1996; 271: 30326–30329.
38.
Stokes KY, Clanton EC, Russell JM, Ross CR, Granger DN. NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circ Res. 2001; 88: 499–505.
This article has been cited by other articles:
 |
|
 |
|
  L. M. Fan, L. Teng, and J.-M. Li Knockout of p47phox Uncovers a Critical Role of p40phox in Reactive Oxygen Species Production in Microvascular Endothelial Cells Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1651 - 1656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Serpillon, B. C. Floyd, R. S. Gupte, S. George, M. Kozicky, V. Neito, F. Recchia, W. Stanley, M. S. Wolin, and S. A. Gupte Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H153 - H162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. He, M. Liang, F. F. Hou, Z. J. Guo, D. Xie, and X. Zhang Ethanol extraction of Picrorhiza scrophulariiflora prevents renal injury in experimental diabetes via anti-inflammation action J. Endocrinol., March 1, 2009; 200(3): 347 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhang, M. Hou, Y. Li, X. Xu, M. Barsoum, Y. Chen, and R. J. Bache NADPH oxidase contributes to coronary endothelial dysfunction in the failing heart Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H840 - H846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fan, D. Sawbridge, V. George, L. Teng, A. Bailey, I. Kitchen, and J.-M. Li Chronic Cocaine-Induced Cardiac Oxidative Stress and Mitogen-Activated Protein Kinase Activation: The Role of Nox2 Oxidase J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 99 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-T. Yen, H.-C. Chen, Y.-D. Lin, C.-C. Shieh, and B. A. Wu-Hsieh Enhancement by Tumor Necrosis Factor Alpha of Dengue Virus-Induced Endothelial Cell Production of Reactive Nitrogen and Oxygen Species Is Key to Hemorrhage Development J. Virol., December 15, 2008; 82(24): 12312 - 12324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Pries, H. Habazettl, G. Ambrosio, P. R. Hansen, J. C. Kaski, V. Schachinger, H. Tillmanns, G. Vassalli, I. Tritto, M. Weis, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings Cardiovasc Res, November 1, 2008; 80(2): 165 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chen, S. Pendyala, V. Natarajan, J. G. N. Garcia, and J. R. Jacobson Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L575 - L583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jun, V. Savransky, A. Nanayakkara, S. Bevans, J. Li, P. L. Smith, and V. Y. Polotsky Intermittent hypoxia has organ-specific effects on oxidative stress Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1274 - R1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Shen, Y. Chen, H. Liu, K. Zhang, T. Zhang, A. Lin, and N. Jing Hydrogen Peroxide Promotes A{beta} Production through JNK-dependent Activation of {gamma}-Secretase J. Biol. Chem., June 20, 2008; 283(25): 17721 - 17730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takahashi, E. Suzuki, R. Takeda, S. Oba, H. Nishimatsu, K. Kimura, T. Nagano, R. Nagai, and Y. Hirata Angiotensin II and tumor necrosis factor-{alpha} synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-{kappa}B, p38, and reactive oxygen species Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2879 - H2888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dworakowski, S. Walker, A. Momin, J. Desai, A. El-Gamel, O. Wendler, M. T. Kearney, and A. M. Shah Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Derived Superoxide and Vascular Endothelial Dysfunction in Human Heart Failure J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1349 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shilo, S. Roy, S. Khanna, and C. K. Sen Evidence for the Involvement of miRNA in Redox Regulated Angiogenic Response of Human Microvascular Endothelial Cells Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 471 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Chitano, L. Wang, S. N. Mason, R. L. Auten, E. N. Potts, W. M. Foster, A. Sturrock, T. P. Kennedy, J. R. Hoidal, and T. M. Murphy Airway smooth muscle relaxation is impaired in mice lacking the p47phox subunit of NAD(P)H oxidase Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L139 - L148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Tephly and A. B. Carter Constitutive NADPH oxidase and increased mitochondrial respiratory chain activity regulate chemokine gene expression Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1143 - L1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Persson The magic mountain or death in Venice: chronic hypoxia may alleviate oxidative stress in the kidney J. Physiol., July 1, 2007; 582(1): 1 - 1. [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Yang, M.-C. Ma, C.-T. Chien, M.-S. Wu, W.-K. Sun, and C.-F. Chen Hypoxic preconditioning attenuates lipopolysaccharide-induced oxidative stress in rat kidneys J. Physiol., July 1, 2007; 582(1): 407 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Donato, I. Eskurza, A. E. Silver, A. S. Levy, G. L. Pierce, P. E. Gates, and D. R. Seals Direct Evidence of Endothelial Oxidative Stress With Aging in Humans: Relation to Impaired Endothelium-Dependent Dilation and Upregulation of Nuclear Factor-{kappa}B Circ. Res., June 8, 2007; 100(11): 1659 - 1666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Bendall, R. Rinze, D. Adlam, A. L. Tatham, J. de Bono, and K. M. Channon Endothelial Nox2 Overexpression Potentiates Vascular Oxidative Stress and Hemodynamic Response to Angiotensin II: Studies in Endothelial-Targeted Nox2 Transgenic Mice Circ. Res., April 13, 2007; 100(7): 1016 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hirono, T. Yoshimoto, N. Suzuki, T. Sugiyama, M. Sakurada, S. Takai, N. Kobayashi, M. Shichiri, and Y. Hirata Angiotensin II Receptor Type 1-Mediated Vascular Oxidative Stress and Proinflammatory Gene Expression in Aldosterone-Induced Hypertension: The Possible Role of Local Renin-Angiotensin System Endocrinology, April 1, 2007; 148(4): 1688 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Doerries, K. Grote, D. Hilfiker-Kleiner, M. Luchtefeld, A. Schaefer, S. M. Holland, S. Sorrentino, C. Manes, B. Schieffer, H. Drexler, et al. Critical Role of the NAD(P)H Oxidase Subunit p47phox for Left Ventricular Remodeling/Dysfunction and Survival After Myocardial Infarction Circ. Res., March 30, 2007; 100(6): 894 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Takimoto and D. A. Kass Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling Hypertension, February 1, 2007; 49(2): 241 - 248. [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, Y. Wang, H. P. Kim, K. Nakahira, S. W. Ryter, and A. M. K. Choi Carbon Monoxide Protects against Hyperoxia-induced Endothelial Cell Apoptosis by Inhibiting Reactive Oxygen Species Formation J. Biol. Chem., January 19, 2007; 282(3): 1718 - 1726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Jiang, S. J. Roberts, S. r. Datla, and G. J. Dusting NO Modulates NADPH Oxidase Function Via Heme Oxygenase-1 in Human Endothelial Cells Hypertension, November 1, 2006; 48(5): 950 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Vogel, J. Orrington-Myers, M. Broman, and A. B. Malik De novo ICAM-1 synthesis in the mouse lung: model of assessment of protein expression in lungs Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L496 - L501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Grote, M. Ortmann, G. Salguero, C. Doerries, U. Landmesser, M. Luchtefeld, R. P. Brandes, W. Gwinner, T. Tschernig, E.-G. Brabant, et al. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation Cardiovasc Res, August 1, 2006; 71(3): 596 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Murdoch, M. Zhang, A. C. Cave, and A. M. Shah NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure Cardiovasc Res, July 15, 2006; 71(2): 208 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ushio-Fukai Redox signaling in angiogenesis: Role of NADPH oxidase Cardiovasc Res, July 15, 2006; 71(2): 226 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Li, M. M. Harraz, W. Zhou, L. N. Zhang, W. Ding, Y. Zhang, T. Eggleston, C. Yeaman, B. Banfi, and J. F. Engelhardt Nox2 and Rac1 Regulate H2O2-Dependent Recruitment of TRAF6 to Endosomal Interleukin-1 Receptor Complexes Mol. Cell. Biol., January 1, 2006; 26(1): 140 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gulbins and P. L. Li Physiological and pathophysiological aspects of ceramide Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R11 - R26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Yang, L. D. Asico, P. Yu, Z. Wang, J. E. Jones, C. S. Escano, X. Wang, M. T. Quinn, D. R. Sibley, G. G. Romero, et al. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R96 - R104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Noronha, J.-M. Li, S. B. Wheatcroft, A. M. Shah, and M. T. Kearney Inducible Nitric Oxide Synthase Has Divergent Effects on Vascular and Metabolic Function in Obesity Diabetes, April 1, 2005; 54(4): 1082 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Li, L. M. Fan, M. R. Christie, and A. M. Shah Acute Tumor Necrosis Factor Alpha Signaling via NADPH Oxidase in Microvascular Endothelial Cells: Role of p47phox Phosphorylation and Binding to TRAF4 Mol. Cell. Biol., March 15, 2005; 25(6): 2320 - 2330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.M. Touyz, G. Yao, M.T. Quinn, P.J. Pagano, and E.L. Schiffrin p47phox Associates With the Cytoskeleton Through Cortactin in Human Vascular Smooth Muscle Cells: Role in NAD(P)H Oxidase Regulation by Angiotensin II Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): 512 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Eligini, S. Stella Barbieri, V. Cavalca, M. Camera, M. Brambilla, M. De Franceschi, E. Tremoli, and S. Colli Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-{alpha} and phorbol ester in human endothelial cells Cardiovasc Res, February 15, 2005; 65(3): 683 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Qian, K. J. Liu, Y. Chen, D. C. Flynn, V. Castranova, and X. Shi Cdc42 Regulates Arsenic-induced NADPH Oxidase Activation and Cell Migration through Actin Filament Reorganization J. Biol. Chem., February 4, 2005; 280(5): 3875 - 3884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Brandes and J. Kreuzer Vascular NADPH oxidases: molecular mechanisms of activation Cardiovasc Res, January 1, 2005; 65(1): 16 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Teissier, A. Nohara, G. Chinetti, R. Paumelle, B. Cariou, J.-C. Fruchart, R. P. Brandes, A. Shah, and B. Staels Peroxisome Proliferator-Activated Receptor {alpha} Induces NADPH Oxidase Activity in Macrophages, Leading to the Generation of LDL with PPAR-{alpha} Activation Properties Circ. Res., December 10, 2004; 95(12): 1174 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. E. Nwariaku, Z. Liu, X. Zhu, D. Nahari, C. Ingle, R. F. Wu, Y. Gu, G. Sarosi, and L. S. Terada NADPH oxidase mediates vascular endothelial cadherin phosphorylation and endothelial dysfunction Blood, November 15, 2004; 104(10): 3214 - 3220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Li and A. M Shah Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1014 - R1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Therade-Matharan, E. Laemmel, J. Duranteau, and E. Vicaut Reoxygenation after hypoxia and glucose depletion causes reactive oxygen species production by mitochondria in HUVEC Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1037 - R1043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Iwasaki, M. Asai, M. Yoshida, T. Nigawara, M. Kambayashi, and N. Nakashima Dehydroepiandrosterone-Sulfate Inhibits Nuclear Factor-{kappa}B-Dependent Transcription in Hepatocytes, Possibly through Antioxidant Effect J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3449 - 3454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Orshal and R. A. Khalil Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1013 - R1023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Li, S. Wheatcroft, L. M. Fan, M. T. Kearney, and A. M. Shah Opposing Roles of p47phox in Basal Versus Angiotensin II-Stimulated Alterations in Vascular O2- Production, Vascular Tone, and Mitogen-Activated Protein Kinase Activation Circulation, March 16, 2004; 109(10): 1307 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Shin, Y. K. Kim, K. Y. Kim, J. H. Lee, and K. W. Hong Remnant Lipoprotein Particles Induce Apoptosis in Endothelial Cells by NAD(P)H Oxidase-Mediated Production of Superoxide and Cytokines via Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Activation: Prevention by Cilostazol Circulation, March 2, 2004; 109(8): 1022 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-L. Chen, Q. Zhang, R. Zhao, and R. M. Medford Superoxide, H2O2, and iron are required for TNF-{alpha}-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1001 - H1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Gertzberg, P. Neumann, V. Rizzo, and A. Johnson NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-{alpha} Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L37 - L48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-S. Chun, K.-H. Lee, E. Choi, S.-Y. Bae, E.-J. Yeo, L. E. Huang, M.-S. Kim, and J.-W. Park Phorbol Ester Stimulates the Nonhypoxic Induction of a Novel Hypoxia-Inducible Factor 1{alpha} Isoform: Implications for Tumor Promotion Cancer Res., December 15, 2003; 63(24): 8700 - 8707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hua, S. Munk, H. Goldberg, I. G. Fantus, and C. I. Whiteside High Glucose-suppressed Endothelin-1 Ca2+ Signaling via NADPH Oxidase and Diacylglycerol-sensitive Protein Kinase C Isozymes in Mesangial Cells J. Biol. Chem., September 5, 2003; 278(36): 33951 - 33962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lassegue and R. E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R277 - R297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Li and A. M. Shah ROS Generation by Nonphagocytic NADPH Oxidase: Potential Relevance in Diabetic Nephropathy J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S221 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.M. Touyz, G. Yao, and E.L. Schiffrin c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 981 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Plotnick, M. C. Corretti, R. A. Vogel, R. Hesslink Jr, and J. A. Wise Effect of supplemental phytonutrients on impairment of the flow-mediated brachialartery vasoactivity after a single high-fat meal J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1744 - 1749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Schiffrin and R. M. Touyz Inflammation and Vascular Hypertrophy Induced by Angiotensin II: Role of NADPH Oxidase-Derived Reactive Oxygen Species Independently of Blood Pressure Elevation? Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 707 - 709. [Full Text] [PDF]
|
|
|
|
|
|
X.-L. Chen, Q. Zhang, R. Zhao, X. Ding, P. E. Tummala, and R. M. Medford Rac1 and Superoxide Are Required for the Expression of Cell Adhesion Molecules Induced by Tumor Necrosis Factor-alpha in Endothelial Cells J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Li and A. M. Shah Mechanism of Endothelial Cell NADPH Oxidase Activation by Angiotensin II. ROLE OF THE p47phox SUBUNIT J. Biol. Chem., March 28, 2003; 278(14): 12094 - 12100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Siflinger-Birnboim and A. Johnson Protein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury Am J Physiol Lung Cell Mol Physiol, March 1, 2003; 284(3): L435 - L451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Leopold, Y.-Y. Zhang, A. W. Scribner, R. C. Stanton, and J. Loscalzo Glucose-6-Phosphate Dehydrogenase Overexpression Decreases Endothelial Cell Oxidant Stress and Increases Bioavailable Nitric Oxide Arterioscler Thromb Vasc Biol, March 1, 2003; 23(3): 411 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. X. Zhang, A.-P. Zou, and P.-L. Li Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H605 - H612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. X. Zhang, F.-X. Yi, A.-P. Zou, and P.-L. Li Role of ceramide in TNF-alpha -induced impairment of endothelium-dependent vasorelaxation in coronary arteries Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1785 - H1794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Li, N. P. Gall, D. J. Grieve, M. Chen, and A. M. Shah Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure Hypertension, October 1, 2002; 40(4): 477 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Landmesser, H. Cai, S. Dikalov, L. McCann, J. Hwang, H. Jo, S. M. Holland, and D. G. Harrison Role of p47phox in Vascular Oxidative Stress and Hypertension Caused by Angiotensin II Hypertension, October 1, 2002; 40(4): 511 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Urbich, E. Dernbach, A. Aicher, A. M. Zeiher, and S. Dimmeler CD40 Ligand Inhibits Endothelial Cell Migration by Increasing Production of Endothelial Reactive Oxygen Species Circulation, August 20, 2002; 106(8): 981 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lassegue and K. K. Griendling Out Phoxing the Endothelium: What's Left Without p47? Circ. Res., February 8, 2002; 90(2): 123 - 124. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||